Resistance to Imatinib Mesylate-induced apoptosis in acute lymphoblastic leukemia is associated with PTEN down-regulation due to promoter hypermethylation

被引：32
|
作者：
Montiel-Duarte, Cristina [1 ]
Cordeu, Lucia [1 ]
Agirre, Xabier [1 ]
Roman-Gomez, Jose [2 ]
Jimenez-Velasco, Antonio [3 ]
Jose-Eneriz, Edurne San [1 ]
Garate, Leire [1 ]
Andreu, Enrique J. [1 ]
Calasanz, Maria Jose [4 ]
Heiniger, Anabel [3 ]
Torres, Antonio [2 ]
Prosper, Felipe [1 ]
机构：
[1] Univ Navarra, Serv Hematol, Clin Univ, Div Canc,Area Terapia Celular,Fdn Appl Med Res, Navarra 31008, Spain
[2] Hosp Reina Sofia, Dept Hematol, Cordoba, Spain
[3] Hosp Carlos Haya, Dept Hematol, Malaga, Spain
[4] Univ Navarra, Sch Sci, Dept Genet, E-31080 Pamplona, Spain
来源：
LEUKEMIA RESEARCH | 2008年 / 32卷 / 05期
关键词：
PTEN; Ph+ ALL; Imatinib; PI3K AKT;
D O I：
10.1016/j.leukres.2007.09.005
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
The aim of our study was to determine the potential mechanism(s) implicated in Imatinib resistance in patients with Ph+ ALL. Resistance of Ph+ ALL cells to Imatinib-induced apoptosis was associated with lack of inhibition of Akt phosphorylation. Addition of the PI3K inhibitor LY294002 to Imatinib significantly increased apoptosis of Ph+ ALL cells. Interestingly, expression of PTEN was reduced in Ph+ ALL cells which was due to PTEN promoter hypermethylation. Treatment of Ph+ ALL cells with 5-Aza-2'-deoxycytidine was associated with an increased expression of PTEN and an increase in cell apoptosis. These results suggest that Imatinib resistance in patients with ALL may be dependent at least in part to PTEN down-regulation due to the abnormal promoter hypermethylation and support the potential role of de-methylating agents for the treatment of patients with Ph+ ALL. (C) 2007 Elsevier Ltd. All rights reserved.
引用
收藏
页码：709 / 716
页数：8
相关论文
共 50 条
  • [1] Philadelphia-negative acute lymphoblastic leukemia developing in a CML patient in imatinib mesylate-induced complete cytogenetic remission
    Cherrier-De Wilde, S
    Rack, K
    Vannuffel, P
    Delannoy, A
    Hagemeijer, A
    LEUKEMIA, 2003, 17 (10) : 2046 - 2048
  • [2] Philadelphia-negative acute lymphoblastic leukemia developing in a CML patient in imatinib mesylate-induced complete cytogenetic remission
    S Cherrier-De Wilde
    K Rack
    P Vannuffel
    A Delannoy
    A Hagemeijer
    Leukemia, 2003, 17 : 2046 - 2048
  • [3] Down-regulation of mitochondrial ATPase by hypermethylation mechanism in chronic myeloid leukemia is associated with multidrug resistance
    Li, R. J.
    Zhang, G. S.
    Chen, Y. H.
    Zhu, J. F.
    Lu, Q. J.
    Gong, F. J.
    Kuang, W. Y.
    ANNALS OF ONCOLOGY, 2010, 21 (07) : 1506 - 1514
  • [4] Effects of NANOG gene down-regulation on the apoptosis of T-cell acute lymphoblastic leukemia cells
    曹江
    China Medical Abstracts(Internal Medicine), 2014, 31 (01) : 55 - 55
  • [5] DOWN-REGULATION OF HSD11B2 IS ASSOCIATED WITH GLYCOLYTIC METABOLISM AND INCREASED SENSITIVITY TO GLUCOCORTICOID INDUCED APOPTOSIS IN LYMPHOBLASTIC LEUKEMIA
    Sai, Shuji
    Saito, Yusuke
    Hirabayashi, Shinsuke
    Chapman, Karen
    Manabe, Atsushi
    PEDIATRIC BLOOD & CANCER, 2024, 71 : S42 - S43
  • [6] HOXA4 Gene Promoter Hypermethylation as an Epigenetic Mechanism Mediating Resistance to Imatinib Mesylate in Chronic Myeloid Leukemia Patients
    Elias, Marjanu Hikmah
    Baba, Abdul Aziz
    Husin, Azlan
    Sulong, Sarina
    Hassan, Rosline
    Sim, Goh Ai
    Wahid, S. Fadilah Abdul
    Ankathil, Ravindran
    BIOMED RESEARCH INTERNATIONAL, 2013, 2013
  • [7] Down-regulation of SULF1 by hypermethylation mediates resistance of hepatocellular carcinoma cells to chemotherapy-induced apoptosis
    Shire, Abdirashid M.
    Lai, Jinping
    Zou, Hongzhi
    Aderca, Ileana
    Moser, Catherine D.
    Jenkins, Robert B.
    Roberts, Lewis R.
    GASTROENTEROLOGY, 2008, 134 (04) : A767 - A768
  • [8] Imatinib mesylate-induced hepato-toxicity in chronic myeloid leukemia demonstrated focal necrosis resembling acute viral hepatitis
    Ohyashiki, K
    Kuriyama, Y
    Nakajima, A
    Tauchi, T
    Ito, Y
    Miyazawa, K
    Kimura, Y
    Serizawa, H
    Ebihara, Y
    LEUKEMIA, 2002, 16 (10) : 2160 - 2161
  • [9] Resistance to TRAIL-induced apoptosis caused by constitutional phosphorylation of Akt and PTEN in acute lymphoblastic leukemia cells
    Dida, Francis
    Li, Yufeng
    Iwao, Atsushi
    Deguchi, Takao
    Azuma, Eiichi
    Komada, Yoshihiro
    EXPERIMENTAL HEMATOLOGY, 2008, 36 (10) : 1343 - 1353
  • [10] Imatinib mesylate-induced long-standing acute hepatitis in a patient with BCR/ABL plus chronic myelogenous leukemia (CML).
    Symeonidis, AS
    Kouraklis-Symeonidis, AH
    Lambropoulou-Karatza, C
    Tsamantas, A
    Thomopoulos, C
    Zoumbos, N
    BLOOD, 2003, 102 (11) : 318B - 318B
12345